Description

Doxorubicin 50 mg Injection

Doxorubicin is a powerful chemotherapy drug used to treat various cancers. The typical starting dose is 60-75 mg/m2, given as a quick intravenous infusion.

Key Points:

• Available in 50 mg/25 mL vials
• Must be administered slowly into a vein to avoid tissue damage
• Patients should stay hydrated during treatment
• Caregivers need to take precautions to avoid contact with bodily fluids
• Can interact with other medications, increasing toxicity

Doxorubicin is a crucial cancer-fighting tool, but requires careful handling and monitoring by healthcare professionals.                                                                                                                                             Key Benefits:

• Effective chemotherapy for leukemia, lymphomas, sarcomas, breast & lung cancer
• Used in combination with other chemo drugs for more effective treatment

Key Ingredients:

• 50 mg doxorubicin hydrochloride per vial
• Lactose monohydrate used as excipient

Dosage

• Typical single agent dose: 60-75 mg/m2 IV over 3-10 minutes every 21 days
• Combination therapy dose: 40-75 mg/m2 every 21-28 days
• Lifetime cumulative dose limit: 450-550 mg/m2 due to cardiac risk

Storage

• Store at 2°C to 8°C (36°F to 46°F), protect from light
• Refrigeration may cause gelling, reverse by warming to room temp

Reviews

• Effective chemo for leukemia, lymphomas, sarcomas, breast/lung cancer
• Often used in combination regimens
• Requires careful administration and monitoring by oncologists